Bringing the patient’s perspective into all phases of development.
Transform data into persuasive evidence to document the clinical, economic, and humanistic value of innovative drugs and devices before and after product approval and launch. Ready to learn how?
Medical and regulatory documentation developed by experienced medical writing teams plays a pivotal role in the success of a clinical research project.
Flex Advantage offers enhanced randomization, clinical supply management capabilities and enables the execution of adaptive clinical trials.
Executing efficient and compliant adaptive trials,
The DIA 2018 Global Annual Meeting is shaping up to be the Life Sciences Event of the Year! Download this year's Preliminary Program to learn why! Get the highlight reel of DIA 2018.
How a powerful forecasting and demand planning technology for managing the end-to-end clinical supply chain can quickly simulate the most common scenarios for each step of your study, create a study baseline and forecast randomization into different dosing groups.
Avoid study delays, increased patient costs, and compromised study data with Bioclinica's program that swiftly and efficiently locates patients who are lost to follow-up, following all privacy and compliance guidelines.
ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 97 locations in 38 countries and has approximately 13,100 employees.
Contracting an in-country clinical depot helps bring costs and timelines under control.
|
|
|
|
|
|
|
|
|